Reaction Details Report a problem with these data
Target
Beta-lactamase
Ligand
BDBM360941
Substrate
n/a
IC50
0.222±n/a nM
Citation
 Bennett, F; Jiang, J; Pasternak, A; Dong, S; Gu, X; Scott, JD; Tang, H; Zhao, Z; Huang, Y; Yang, D; Young, K; Xiao, L; Zhang, Z; Fu, J Metallo-beta-lactamase inhibitors US Patent  US10544130 Publication Date 1/28/2020 
Target
Name:
Beta-lactamase
Synonyms:
n/a
Type:
Protein
Mol. Mass.:
29508.45
Organism:
n/a
Description:
Q2QC95
Residue:
266
Sequence:
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
 
Inhibitor
Name:
BDBM360941
Synonyms:
3-(4-(2-amino- benzo[d]thiazol- 4-yl)-2-sulfamoyl-3- (1H-tetrazol-5-yl) phenylsulfonamido) quinuclidin- 1-ium 2,2,2- trifluoroacetate | US10221163, Example 97 | US10544130, Example 97
Type:
Small organic molecule
Emp. Form.:
C21H23N9O4S3
Mol. Mass.:
561.66
SMILES:
Nc1nc2c(cccc2s1)-c1ccc(c(c1-c1nnn[nH]1)S(N)(=O)=O)S(=O)(=O)NC1CN2CCC1CC2 |(-6.65,-1.33,;-5.88,-0,;-4.34,.16,;-4.02,1.67,;-2.69,2.44,;-2.69,3.98,;-4.02,4.75,;-5.36,3.98,;-5.36,2.44,;-6.5,1.41,;-1.36,1.67,;-1.36,.13,;-.02,-.64,;1.31,.13,;1.31,1.67,;-.02,2.44,;-.02,3.98,;1.22,4.88,;.75,6.35,;-.79,6.35,;-1.27,4.88,;2.64,2.44,;3.98,3.21,;3.98,1.67,;3.04,3.92,;2.64,-.64,;3.98,-1.41,;3.98,.13,;2.64,-2.18,;3.98,-2.95,;3.98,-4.49,;5.31,-5.26,;6.65,-4.49,;6.65,-2.95,;5.31,-2.18,;6.01,-3.4,;4.82,-4.09,)|
Structure:
Search PDB for entries with ligand similarity: